IPO News & Commentary
Get the latest insights on new stocks
- California-based River City Bank prices downsized IPO at $45, below the range 08/06/26
- Cardiovascular diseases biotech Braveheart Bio prices upsized IPO at $18, above the range 08/06/26
- Messaging infrastructure provider Spectral Capital sets terms for $15 million Nasdaq uplisting 08/05/26
- SPAC Gravity Acquisition files for a $250 million IPO, targeting North America, Europe, and Asia 08/05/26
- SPAC TCGX Acquisition prices $75 million IPO, targeting healthcare in Asia 08/05/26
- Immune-focused biotech Attovia Therapeutics prices previously upsized IPO at $17, as expected 08/05/26
- IPO Weekly Weigh-in: Cerebras' $24B backlog is really just one customer 08/05/26
See more
IPO News By Industry
- Hong Kong digital marketing provider Poche Technology ups range to $5 to $7 ahead of $38 million US IPO 08/06/26
- SME marketing provider Hartford Creative Group more than triples shares offered ahead of $20 million Nasdaq uplisting 06/26/26
- Canada-based content production company Ambitious Entertainment ups shares offered by 12% ahead of $18 million US IPO 06/22/26
NYSE IPO News
- SPAC 1776 Acquisition files for a $150 million IPO, targeting tech-enabled businesses 08/03/26
- Chinese copper foils producer Londian Wason New Energy Tech sets terms for $75 million US IPO 08/03/26
- IPO Winners & Losers: Biotech Soars, Jersey Mike's Misses, and SpaceX Faces the Lockup 08/03/26
- US IPO Weekly Recap: Jersey Mike’s and Reformation underwhelm 07/31/26
- Blackstone-backed sandwich chain Jersey Mike's Subs prices IPO at the $23 midpoint 07/30/26
Nasdaq IPO News
- Latigo Biotherapeutics prices upsized IPO at $18, the high end of the range 08/06/26
- SPAC Rainier Acquisition files for a $75 million IPO, targeting life sciences 08/06/26
- Hong Kong digital marketing provider Poche Technology ups range to $5 to $7 ahead of $38 million US IPO 08/06/26
- California-based River City Bank prices downsized IPO at $45, below the range 08/06/26
- Cardiovascular diseases biotech Braveheart Bio prices upsized IPO at $18, above the range 08/06/26
Be the in-house IPO Expert
Our clients are focused on catalyzing growth and creating value.
Not scouring the web for IPO data.
Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.
Latigo Biotherapeutics prices upsized IPO at $18, the high end of the range
Latigo Biotherapeutics, a Phase 3-ready biotech developing non-opioid therapies for acute and chronic pain, raised $346 million by offering 19.2 million shares at $18, the high end of the $16 to $18 range. The company had originally planned to offer 16 million...read more
SPAC Rainier Acquisition files for a $75 million IPO, targeting life sciences
Rainier Acquisition, a blank check company target life sciences, filed on Thursday with the SEC to raise up to $75 million in an initial public offering. The company plans to raise $75 million by offering 7.5 million units at $10. Each unit consists of one...read more
Hong Kong digital marketing provider Poche Technology ups range to $5 to $7 ahead of $38 million US IPO
Poche Technology, a Hong Kong-based provider of digital marketing solutions for advertisers, raised the proposed deal size for its upcoming IPO on Thursday. The Hong Kong, China-based company now plans to raise $38 million by offering 6.3 million shares at a...read more